| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.36 | 5e-08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.35 | 5e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 0.0007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0009 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.1 |